Abby Douglas Profile
Abby Douglas

@AbbyPDouglas

Followers
498
Following
11K
Media
34
Statuses
538

Infectious diseases physician at Peter Mac and Austin Health, post doc fellow of the National Centre for Infections in Cancer. Opinions are my own

Melbourne, Victoria
Joined August 2017
Don't wanna be here? Send us removal request.
@AbbyPDouglas
Abby Douglas
3 months
Very exciting to see some clinical data on fosmanogepix in invasive mounds! So much hard work has gone into developing these much-needed drugs, great to see it in the real world. We have reason to hope for a better future for our challenging IMI cases. #TID.
@CIDJournal
Clinical Infectious Diseases
3 months
Fosmanogepix for the Treatment of Invasive Mold Diseases Caused by Aspergillus Species and Rare Molds: A Phase 2, Open-Label Study (AEGIS). ✅ Just Accepted.
0
0
1
@AbbyPDouglas
Abby Douglas
9 months
Hi all, I am heading across to bluesky to see if the sky is indeed bluer there. Like others, I am keen for more medical science and medicine-related content and discussion. I’ll be abbydouglas@bsky.social
0
0
1
@AbbyPDouglas
Abby Douglas
9 months
RT @MichaelGIsonMD: Amazing resource for graphics!.
0
3
0
@AbbyPDouglas
Abby Douglas
9 months
A fantastic line up of local and international speakers, talking about the cutting edge of fungal infection management! See you there.
@NCICancer
NCIC
9 months
📢 ONLY 2 WEEKS AWAY! 📢 2024 NCIC SYMPOSIUM.Register here - NCIC (.Topic: Tackling Fungal infections - Novel Immune & Diagnostic Approaches!
Tweet media one
0
0
3
@AbbyPDouglas
Abby Douglas
10 months
RT @MichaelGIsonMD: It’s not too late to register and join for the ESGICH-ESGAP Stewardship in the Immunocompromised Host - with a great li….
0
10
0
@AbbyPDouglas
Abby Douglas
11 months
Really looking forward to co-chairing this important and stimulating session! Much to do in the AMS space in ICH, we will hear from experts about recent research and new approaches. #TxID.
@MichaelGIsonMD
Michael Ison, MD MS
11 months
@AbbyPDouglas @TrubianoJason @mularoni Presentations include:. 🔥Malgorzata Mikulksa: Challenges of Optimizing Antibiotics in Fever & Neutropenia. 🔥@mularoni: Approaches to Stewardship in SOT Recipients. 🔥@TrubianoJason: Addressing Antimicrobial Allergies in Immunocompromised Patients.
0
2
6
@AbbyPDouglas
Abby Douglas
11 months
RT @MichaelGIsonMD: Please join ESGICH for our first session of our Webinar Series on September 24 at 12pm CET/8pm Melbourne/6am EST. This….
0
7
0
@AbbyPDouglas
Abby Douglas
11 months
RT @NCICancer: Register now for our hybrid annual Symposium "Tackling Fungal infections" 10am Melbourne, Australia….
0
6
0
@AbbyPDouglas
Abby Douglas
11 months
Excited to see this out in the world! Great work from Dr Jess Chiodo-Reidy and all. Pre-neutropenic fever in AML and alloHCT is common, rarely has an infective cause and leads to a lot of antimicrobial use. More work in this space needed @NCICancer @monicaslavin @NCAS_Aus #txid.
@OFIDJournal
Open Forum Infectious Diseases
11 months
Pre-neutropenic fever in patients with hematological malignancies: a novel target for antimicrobial stewardship. ✅ Just Accepted.🔗
Tweet media one
2
0
8
@AbbyPDouglas
Abby Douglas
11 months
RT @ASIDANZ: Coming up soon - 20 August!.
0
1
0
@AbbyPDouglas
Abby Douglas
1 year
RT @michyong2: Want to know how to join our research team @NCICancer?Want to ask an in depth question or evaluate how well we are managing….
0
2
0
@AbbyPDouglas
Abby Douglas
1 year
RT @CoffeyTimeNews: Take a minute. Watch this. ‘A racist abusive coward that could permanently damage the fabric of our society’. Celebs….
0
14K
0
@AbbyPDouglas
Abby Douglas
1 year
What a great conference! So many amazing people in one room- a real honor to receive an award in their company. Thanks to Dr Murat Akova and the organising committee for a mammoth effort, and well done to the @NCICancer crew- so much good work on display 😊. #TID.
@NCICancer
NCIC
1 year
NCIC had a hugely successful #ICHS2024 with A/Prof Michelle Yong being announced as the council Vice President and Dr Abby Douglas being awarded best poster presentation. See you all again next year in Houston, Texas with @ChemalyRoy!
Tweet media one
Tweet media two
Tweet media three
Tweet media four
0
0
10
@AbbyPDouglas
Abby Douglas
1 year
An amazing talk my Prof Kauffman- congratulations and thank you for all you have done for the society.
@MichaelGIsonMD
Michael Ison, MD MS
1 year
@IchsGlobal Lifetime Achievement Award Winner Carol Kauffman @umichmedicine gave a history of the society including a world tour of its meetings #ICHS2024
Tweet media one
Tweet media two
Tweet media three
Tweet media four
0
0
6
@AbbyPDouglas
Abby Douglas
1 year
RT @ASIDANZ: On tomorrow. Don't miss the @ASIDANZ ANZMIG & The Asia Fungal Working Group (AFWG) @AFWGonline joint webinar 6 Feb 2024 7.30pm….
0
2
0
@AbbyPDouglas
Abby Douglas
1 year
RT @sarah_delliere: Today is world #aspergillosis day 🍄. To all the Asp Fu fighters ✊🏻👩🏼‍⚕️🧑🏽‍🔬
Tweet media one
0
12
0
@AbbyPDouglas
Abby Douglas
2 years
Thank you @thelancethaem for inviting me to review this important study. Australia has a long way to catch up to other parts of the world with good access to letermovir for those at risk. Do we need it beyond 100 days though? probably a cost-benefit decision #cmv #tid @NCICancer.
@TheLancetHaem
The Lancet Haematology
2 years
"Crucially, in the absence of a mortality benefit, a cost-effectiveness analysis would be important. In relation to letermovir prophylaxis, the question remains: how long is long enough?". Linked comment by @AbbyPDouglas & Monica A Slavin.
0
1
13
@AbbyPDouglas
Abby Douglas
2 years
Very pleased to share our study on cost-effectiveness of FDG-PET/CT for persistent/recurrent neutropenic fever in high-risk pts, based on the PIPPIN RCT. FDG-PET/CT overall less expensive whilst aiding in antimicrobial rationalization ⁦@NCICancer
Tweet card summary image
cancerimagingjournal.biomedcentral.com
Background A recent randomised trial demonstrated [18F]fluorodeoxyglucose positron-emission tomography in combination with low-dose CT (FDG-PET/CT), compared to standard of care computed tomography...
0
6
19
@AbbyPDouglas
Abby Douglas
2 years
1
0
1
@AbbyPDouglas
Abby Douglas
2 years
Very thrilled and excited to receive an investigator grant to continue my research into neutropenic fever, invasive fungal infections and rationalising antibiotic use. Thanks to #NHMRC
petermac.org
7
1
44